BYDUREON BCise Injectable medicine now available in the US for type-2 diabetes patients11 Jan 2018
The new formulation is proven to reduce blood sugar levels and may have the added benefit of weight loss.
AstraZeneca has announced that BYDUREON BCise (exenatide extended-release) injectable suspension 2 mg is now available in pharmacies across the US. BYDUREON BCise was recently approved by the FDA for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral antidiabetic medicines in addition to diet and exercise, to improve glycemic control.
BYDUREON BCise is a new formulation of BYDUREON (exenatide extended-release) injectable suspension 2 mg in an improved once-weekly, single-dose autoinjector device. It is designed for patient ease and convenience in a pre-filled device with a pre-attached hidden needle. The new formulation of BYDUREON BCise is proven to reduce blood sugar levels and may have the added benefit of weight loss, although not a weight loss medicine. The medication is administered in three simple steps – mix, unlock, inject.
Rod Wooten, Vice President, Cardiovascular and Metabolic Diseases, AstraZeneca, said: "We're pleased that BYDUREON BCise is now available for adults with type 2 diabetes. This new formulation helps to provide consistent glycemic control, in addition to the powerful HbA1c reductions and added benefit of weight loss, now in a simply improved device."
Across two clinical trials, average HbA1c reductions of up to 1.4% and average weight loss of up to 3.1 pounds were achieved when used as monotherapy or as an add-on to metformin, a sulfonylurea, a thiazolidinedione, or any combination of two of these oral antidiabetic medicines at 28 weeks. The most common adverse reactions reported in ≥5% of patients in clinical trials were nausea (8.2%) and adverse events associated with injection-site nodules (10.5%).
Virginia Valentine APRN, BC-ADM, CDE, FAADE, said: "Managing type 2 diabetes is complicated and requires daily attention to meal planning, exercise and medications. A once-weekly prescription option in an easy-to-use device, like BYDUREON BCise, can help simplify a patient's regimen and help them achieve diabetes control goals."
TraceLink unveils Product Information Manager for its digital information sharing platform
12 Jul 2018
Product Information Manager addresses a broad range of use cases, beginning with saleable returns.Read more
Stability studies trends
10 Jul 2018
Dr Ramesh Jagadeesan, Sr. Director - Analytical Development at Recipharm, speaks to CPhI Online on the trends and challenges involved with conducting stability studies for firms that supply to multiple countries, and the advantages of using a contracto...Read more
Recipharm launches standalone serialisation service
5 Jul 2018
Company will be able to add 2D codes, human-readable text and tamper evidence to pre-packed medicines using existing equipment across its facilities.Read more
CPhI Worldwide opens entries for 15th Annual Pharma Awards
5 Jul 2018
Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.Read more
Catalent to acquire Juniper Pharmaceuticals
5 Jul 2018
$133 million deal adds European Early Development Center of Excellence to global network.Read more
Insights in lyophilization science
4 Jul 2018
The latest developments in process development, nucleation control, scale-up of freeze drying cycles and development in lyophilization technology.Read more
Bosch to sell its packaging business
4 Jul 2018
Packaging technology is not a core Bosch business.Read more
Plasticell leads gene therapy manufacturing consortium
3 Jul 2018
Consortium to develop advanced technologies for the manufacturing of ex vivo gene therapies.Read more
Forté Pharma strengthens its leadership in weight control in France
1 Jul 2018
Company consolidated as one of the leading laboratories in weight control thanks to the development of its existing range and new launches.Read more
I Holland woos exhibition visitors with new tabletting technologies
28 Jun 2018
Company's Wear Indicator Layer attracts the most attention.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation